
Heron Therapeutics Inc
HRTXNASDAQ NMS - GLOBAL MARKETKey Statistics
Open
$0.8730
Day High
$0.8900
Day Low
$0.8501
Prev. Close
$0.8919
VolumeShares traded today.
1.76M
Avg. VolumeAverage daily volume.
—
Market CapTotal value of all shares = price × shares outstanding.
$164.69M
P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.
-5.00
Forward P/EP/E based on forecast next-year earnings.
—
P/B RatioPrice-to-Book: share price ÷ book value per share.
—
52W HighHighest price over the past 52 weeks.
$2.30
52W LowLowest price over the past 52 weeks.
$0.7400
50D MAAverage closing price over the last 50 trading days.
$0.9508
200D MAAverage closing price over the last 200 trading days.
$1.17
Dividend YieldAnnual dividend ÷ share price, as a %.
—
BetaVolatility vs the market. >1 = more volatile than the S&P 500.
—
Performance
1W
-0.1%1M
-26.9%6M
-20.2%YTD
-30.9%1Y
-54.9%About
Antibe Therapeutics was a Toronto-based pharmaceutical company that develops pain and inflammation-reducing drugs based on gaseous mediator technology. Antibe was founded by John L. Wallace, also a co-founder of NicOx, the first company to develop drugs utilizing gaseous mediators. Founded in 2009, the company listed on the TSX Venture Exchange in 2013 and was moved to the Toronto Stock Exchange in November 2020. In 2015, Antibe acquired Citagenix, a distributor involved in regenerative medicine.
www.herontx.com/Company Facts
Similar stocks
Health CareSentiment
Latest News
Social Noise
Price Alerts
Loading…
Trade HRTX
Brokers available in your region (US)
Affiliate links — we may earn a commission. CFDs are risky.